Redefining Expectations in Rare Disease About Amicus Amicus is a wholly owned subsidiary of BioMarin Pharmaceutical Inc., a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Learn More About BioMarin We are guided by people living with rare diseases across the globe.